United States · FDA National Drug Code directory
SPEVIGO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50222-360_40cef378-e90e-4891-812a-b3c889dc9193
- Product NDC
- 50222-360
- Form
- INJECTION
- Composition / generic term
- spesolimab
- Labeler
- LEO Pharma Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260309
- Source listing expiry
- 20271231
Source-listed ingredients
- SPESOLIMAB — 60 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 VIAL, GLASS in 1 CARTON (50222-360-72) / 7.5 mL in 1 VIAL, GLASS · 50222-360-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →